Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Net sales $ 560,229 $ 1,570,037
Cost of sales 1,714,370 4,312,088
Gross loss (1,154,141) (2,742,051)
Operating expenses    
Selling, general and administrative 2,400,147 1,899,582
Research and development 2,337,631 3,243,322
Total operating expenses 4,737,778 5,142,904
Interest expense, net 525,887 35,651
Net loss $ (6,417,806) $ (7,920,606)
Basic and diluted loss per share $ (0.16) $ (0.24)
Weighted average number of common shares outstanding 40,258,234 32,965,419